Nls Pharmaceutics Ltd (NLSP) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket
 


Nls Pharmaceutics Ltd  (NASDAQ: NLSP)

Nls Pharmaceutics Ltd Profitability Comparisons

Select each Category to receive further Information




NLSP Profitability Ratio

Company Industry Sector S&P 500
Gross Profit Margin (Q4 MRQ) - 74.24 % 71.46 % 55.11 %
Gross Margin (Q4 TTM) - 74.52 % 68.39 % 49.39 %
Gross Profit Margin 5 Yr. Avg. - 66.05 % 64.67 % 47.07 %
EBITDA Margin (Q4 MRQ) - 25.29 % 22.25 % 23.72 %
EBITDA Margin (Q4 TTM) - 21.23 % 19.16 % 20.3 %
EBITDA Margin 5 Yr. Avg. - 45.98 % 31.17 % 22.06 %
Operating Margin (Q4 MRQ) - 22.46 % 19.05 % 20.92 %
Operating Margin (Q4 TTM) - 17.54 % 15.8 % 17.7 %
Operating Margin 5 Yr. Avg. - 15.55 % 14.41 % 17.09 %
Pre-Tax Profit Margin (Q4 MRQ) - 19.07 % 14.98 % 12.27 %
Pre-Tax Profit Margin (Q4 TTM) - 15.78 % 13.04 % 12.46 %
Pre-Tax Profit Margin 5 Yr. Avg. - 13.09 % 10.45 % 12.49 %
Net Margin (Q4 MRQ) - 16.86 % 12.95 % 10.15 %
Net Margin (Q4 TTM) - 20.6 % 14.99 % 10.36 %
Net Margin 5 Yr. Avg. - 6.22 % 6.23 % 9.95 %